Elaine Chen
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
Novo also invested much less in R&D than competitor Eli Lilly
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
June 5, 2025 at 4:13 PM
Novo also invested much less in R&D than competitor Eli Lilly
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
Pfizer also replaced language saying that it partners with groups that “are dedicated to championing historically underrepresented populations” and deleted a list of its partners
www.statnews.com/2025/02/27/p...
www.statnews.com/2025/02/27/p...
February 28, 2025 at 2:08 PM
Pfizer also replaced language saying that it partners with groups that “are dedicated to championing historically underrepresented populations” and deleted a list of its partners
www.statnews.com/2025/02/27/p...
www.statnews.com/2025/02/27/p...
I echo what Emory has said and if you want to learn about promotions we have for our subscriptions or questions on how to get institutional access or on the story itself, feel free to DM
February 20, 2025 at 5:16 PM
I echo what Emory has said and if you want to learn about promotions we have for our subscriptions or questions on how to get institutional access or on the story itself, feel free to DM
New obesity treatments have been transformational, but the fixation on more weight loss may not be in patients' best interests, doctors say.
Rapid and extreme weight loss may lead to too much muscle loss, a weakened immune system, and other risks
www.statnews.com/2025/02/20/t...
Rapid and extreme weight loss may lead to too much muscle loss, a weakened immune system, and other risks
www.statnews.com/2025/02/20/t...
How much weight loss is too much? Pharma is pushing the limit with new obesity drugs
How much weight loss is too much? Pharma is pushing the limit with new obesity drugs.
www.statnews.com
February 20, 2025 at 2:03 PM
New obesity treatments have been transformational, but the fixation on more weight loss may not be in patients' best interests, doctors say.
Rapid and extreme weight loss may lead to too much muscle loss, a weakened immune system, and other risks
www.statnews.com/2025/02/20/t...
Rapid and extreme weight loss may lead to too much muscle loss, a weakened immune system, and other risks
www.statnews.com/2025/02/20/t...